These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 15601665)

  • 21. Medicare program; changes to the Medicare Advantage and the Medicare prescription drug benefit programs for contract year 2013 and other changes. Final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2012 Apr; 77(71):22072-175. PubMed ID: 22606715
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medicare Advantage reforms: comparing House and Senate bills.
    Biles B; Arnold G
    Issue Brief (Commonw Fund); 2009 Dec; 74():1-12. PubMed ID: 20183948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medicare disadvantaged and the search for the elusive 'level playing field'.
    Berenson RA
    Health Aff (Millwood); 2004; Suppl Web Exclusives():W4-572-85. PubMed ID: 15601664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cost of privatization: extra payments to Medicare Advantage plans.
    Biles B; Nicholas LH; Cooper BS
    Issue Brief (Commonw Fund); 2004 May; (750):1-12. PubMed ID: 15154416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Continuing effects of Medicare Part D on rural independent pharmacies who are the sole retail provider in their community.
    Radford A; Mason M; Richardson I; Rutledge S; Poley S; Mueller K; Slifkin R
    Res Social Adm Pharm; 2009 Mar; 5(1):17-30. PubMed ID: 19285286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Falling into the doughnut hole: drug spending among beneficiaries with end-stage renal disease under Medicare Part D plans.
    Patel UD; Davis MM
    J Am Soc Nephrol; 2006 Sep; 17(9):2546-53. PubMed ID: 16855016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medicare beneficiary out-of-pocket costs: are Medicare Advantage Plans a better deal?
    Biles B; Hersch Nicholas L; Guterman Stuart S
    Issue Brief (Commonw Fund); 2006 May; 19():1-16. PubMed ID: 16733884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Medicare Prescription Drug, Improvement, and Modernization Act of 2003.
    Emmer S; Allendorf L
    J Am Geriatr Soc; 2004 Jun; 52(6):1013-5. PubMed ID: 15161471
    [No Abstract]   [Full Text] [Related]  

  • 29. The new Medicare Advantage a disadvantage for providers?
    O'Hare PK
    Healthc Financ Manage; 2004 Mar; 58(3):36-40. PubMed ID: 15029797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Private plans in medicare: another look.
    Gold M
    Health Aff (Millwood); 2005; 24(5):1302-10. PubMed ID: 16162577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Strategic choices for managed care plans under the Modernization Act of 2003.
    Shekhdar AR
    J Health Law; 2004; 37(3):429-44. PubMed ID: 15648536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A first look at the new Medicare prescription drug plans.
    Frakt AB; Pizer SD
    Health Aff (Millwood); 2006; 25(4):W252-61. PubMed ID: 16720588
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medicare Advantage in the era of health reform: progress in leveling the playing field.
    Biles B; Arnold G; Guterman S
    Issue Brief (Commonw Fund); 2011 Mar; 5():1-14. PubMed ID: 21456325
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medicare Advantage in 2006-2007: what Congress intended?
    Gold M
    Health Aff (Millwood); 2007; 26(4):w445-55. PubMed ID: 17504767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medicare Part D: how do vulnerable beneficiaries fare?
    Summer L; Nemore P; Finberg J
    Issue Brief (Commonw Fund); 2008 Apr; 35():1-11. PubMed ID: 18536146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Status report on Medicare Part D enrollment in 2006: analysis of plan-specific market share and coverage.
    Cubanski J; Neuman P
    Health Aff (Millwood); 2007; 26(1):w1-12. PubMed ID: 17118944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular medicine, the Medicare drug benefit, and the need for cost control.
    Gillick MR
    J Am Geriatr Soc; 2006 Sep; 54(9):1442-6. PubMed ID: 16970656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coverage and use of prescription drugs in nursing homes: implications for the medicare modernization act.
    Stuart B; Simoni-Wastila L; Baysac F; Shaffer T; Shea D
    Med Care; 2006 Mar; 44(3):243-9. PubMed ID: 16501395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lessons for Medicare Part D in the hemodialysis community.
    Nayeem AI; Chertow GM
    BMC Nephrol; 2006 Jul; 7():11. PubMed ID: 16824211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Uncovering value in the Medicare+Choice marketplace.
    Ahl D
    Manag Care Q; 2002; 10(2):47-51. PubMed ID: 12148482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.